Stockreport

Tango Therapeutics Announces $225 Million Financing

Tango Therapeutics, Inc.  (TNGX) 
PDF BOSTON, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (Nasdaq: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the n [Read more]